Search Tag: prostate MRI

2025 24 Sep

  Prostate cancer remains a major global burden, while diagnostic pathways continue to evolve to balance accuracy, invasiveness and resource use. Multiparametric MRI is central to noninvasive assessment but can be affected by motion, interpretation variability and scan duration. Researchers have reported an in silico evaluation of MRI histopathology,...Read more

2025 02 Sep

  Magnetic resonance imaging has become central to prostate cancer diagnosis and risk stratification, yet variability in image quality can undermine clinical pathways. A multi-institutional analysis assessed how prostate imaging quality, graded with the updated Prostate Imaging Quality Score version 2 (PI-QUAL v2), affects the diagnostic performance...Read more

2025 25 Aug

Prostate cancer remains one of the most prevalent malignancies affecting men worldwide and poses a major burden on health systems. While biparametric MRI is recommended as a primary diagnostic approach, its standard assessment method—PI-RADS—has limitations, particularly a high false-positive rate. These limitations often result in unnecessary biopsies,...Read more

2025 04 May

Prostate cancer detection relies heavily on multiparametric magnetic resonance imaging (mpMRI), particularly T2-weighted imaging (T2WI). However, image quality (IQ) varies across scans, often due to motion artifacts or hardware limitations. This variability can prompt unnecessary repeat scans, consuming time and resources. In response, researchers...Read more

2025 04 May

Prostate cancer detection relies heavily on multiparametric magnetic resonance imaging (mpMRI), particularly T2-weighted imaging (T2WI). However, image quality (IQ) varies across scans, often due to motion artifacts or hardware limitations. This variability can prompt unnecessary repeat scans, consuming time and resources. In response, researchers...Read more